Pancreatitis in patients with organic acidemias. 1994

S G Kahler, and W G Sherwood, and D Woolf, and S T Lawless, and A Zaritsky, and J Bonham, and C J Taylor, and J T Clarke, and P Durie, and J V Leonard
Department of Pediatrics, Duke University Medical Center, Durham, NC 27710.

OBJECTIVE The discovery of pancreatitis in two children with methylmalonic acidemia led us to review the experience with pancreatitis in a large number of patients with organic acidemias to determine whether pancreatitis is an important complication of these disorders. METHODS Case series. METHODS Pediatric metabolism services at five tertiary care centers. METHODS Records of all patients with organic acidemias followed at the five institutions during the past 10 years were reviewed. Pancreatitis was recognized by symptoms and laboratory findings and confirmed by imaging studies, surgery, or autopsy. At three institutions all cases of pancreatitis in children younger than 10 years were reviewed. RESULTS Nine children with pancreatitis (seven with acute and two with chronic cases) were identified among 108 children with branched-chain organic acidemias. They ranged in age from 13 months to 9 years. Five had methylmalonic acidemia, three had isovaleric acidemia, and one had maple syrup urine disease. There were three deaths; acute hemorrhagic pancreatitis occurred in two children, and chronic pancreatitis was found at autopsy in a third. All three patients with isovaleric acidemia and pancreatitis were identified after the occurrence of pancreatitis. The survey of pancreatitis at three institutions found 57 other patients (none with an inborn error) in addition to three patients with inborn errors included in this study. CONCLUSIONS Acute or chronic pancreatitis may complicate branched-chain organic acidemias and must be considered in the assessment of patients with these disorders who have acute clinical deterioration and vomiting, abdominal pain, encephalopathy or shock, or milder symptoms. Conversely, an inborn error of organic acid metabolism should be considered in children with pancreatitis of unknown origin.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D008375 Maple Syrup Urine Disease An autosomal recessive inherited disorder with multiple forms of phenotypic expression, caused by a defect in the oxidative decarboxylation of branched-chain amino acids (AMINO ACIDS, BRANCHED-CHAIN). These metabolites accumulate in body fluids and render a "maple syrup" odor. The disease is divided into classic, intermediate, intermittent, and thiamine responsive subtypes. The classic form presents in the first week of life with ketoacidosis, hypoglycemia, emesis, neonatal seizures, and hypertonia. The intermediate and intermittent forms present in childhood or later with acute episodes of ataxia and vomiting. (From Adams et al., Principles of Neurology, 6th ed, p936) Branched-Chain Ketoaciduria,Thiamine Responsive Maple Syrup Urine Disease,BCKD Deficiency,Branched-Chain alpha-Keto Acid Dehydrogenase Deficiency,Classic Maple Syrup Urine Disease,Classical Maple Syrup Urine Disease,Intermediate Maple Syrup Urine Disease,Intermittent Maple Syrup Urine Disease,Keto Acid Decarboxylase Deficiency,MSUD (Maple Syrup Urine Disease),Maple Syrup Urine Disease, Classic,Maple Syrup Urine Disease, Classical,Maple Syrup Urine Disease, Intermediate,Maple Syrup Urine Disease, Intermittent,Maple Syrup Urine Disease, Thiamine Responsive,Maple Syrup Urine Disease, Thiamine-Responsive,Branched Chain Ketoaciduria,Branched Chain alpha Keto Acid Dehydrogenase Deficiency,Branched-Chain Ketoacidurias,Ketoaciduria, Branched-Chain,Ketoacidurias, Branched-Chain
D008764 Methylmalonic Acid A malonic acid derivative which is a vital intermediate in the metabolism of fat and protein. Abnormalities in methylmalonic acid metabolism lead to methylmalonic aciduria. This metabolic disease is attributed to a block in the enzymatic conversion of methylmalonyl CoA to succinyl CoA. Acid, Methylmalonic
D010088 Oxidoreductases The class of all enzymes catalyzing oxidoreduction reactions. The substrate that is oxidized is regarded as a hydrogen donor. The systematic name is based on donor:acceptor oxidoreductase. The recommended name will be dehydrogenase, wherever this is possible; as an alternative, reductase can be used. Oxidase is only used in cases where O2 is the acceptor. (Enzyme Nomenclature, 1992, p9) Dehydrogenases,Oxidases,Oxidoreductase,Reductases,Dehydrogenase,Oxidase,Reductase
D010195 Pancreatitis INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis. Acute Edematous Pancreatitis,Acute Pancreatitis,Pancreatic Parenchyma with Edema,Pancreatic Parenchymal Edema,Pancreatitis, Acute,Pancreatitis, Acute Edematous,Peripancreatic Fat Necrosis,Acute Edematous Pancreatitides,Acute Pancreatitides,Edema, Pancreatic Parenchymal,Edematous Pancreatitides, Acute,Edematous Pancreatitis, Acute,Fat Necrosis, Peripancreatic,Necrosis, Peripancreatic Fat,Pancreatic Parenchymal Edemas,Pancreatitides, Acute,Pancreatitides, Acute Edematous,Parenchymal Edema, Pancreatic,Peripancreatic Fat Necroses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic

Related Publications

S G Kahler, and W G Sherwood, and D Woolf, and S T Lawless, and A Zaritsky, and J Bonham, and C J Taylor, and J T Clarke, and P Durie, and J V Leonard
May 1995, The Journal of pediatrics,
S G Kahler, and W G Sherwood, and D Woolf, and S T Lawless, and A Zaritsky, and J Bonham, and C J Taylor, and J T Clarke, and P Durie, and J V Leonard
March 1976, Clinics in perinatology,
S G Kahler, and W G Sherwood, and D Woolf, and S T Lawless, and A Zaritsky, and J Bonham, and C J Taylor, and J T Clarke, and P Durie, and J V Leonard
March 2022, Pediatrics in review,
S G Kahler, and W G Sherwood, and D Woolf, and S T Lawless, and A Zaritsky, and J Bonham, and C J Taylor, and J T Clarke, and P Durie, and J V Leonard
January 1988, Texas medicine,
S G Kahler, and W G Sherwood, and D Woolf, and S T Lawless, and A Zaritsky, and J Bonham, and C J Taylor, and J T Clarke, and P Durie, and J V Leonard
January 2002, Archives of medical research,
S G Kahler, and W G Sherwood, and D Woolf, and S T Lawless, and A Zaritsky, and J Bonham, and C J Taylor, and J T Clarke, and P Durie, and J V Leonard
March 2021, Molecular genetics and metabolism reports,
S G Kahler, and W G Sherwood, and D Woolf, and S T Lawless, and A Zaritsky, and J Bonham, and C J Taylor, and J T Clarke, and P Durie, and J V Leonard
January 1983, La Pediatria,
S G Kahler, and W G Sherwood, and D Woolf, and S T Lawless, and A Zaritsky, and J Bonham, and C J Taylor, and J T Clarke, and P Durie, and J V Leonard
November 1994, Brain & development,
S G Kahler, and W G Sherwood, and D Woolf, and S T Lawless, and A Zaritsky, and J Bonham, and C J Taylor, and J T Clarke, and P Durie, and J V Leonard
June 2021, American journal of medical genetics. Part A,
S G Kahler, and W G Sherwood, and D Woolf, and S T Lawless, and A Zaritsky, and J Bonham, and C J Taylor, and J T Clarke, and P Durie, and J V Leonard
November 1987, Harefuah,
Copied contents to your clipboard!